Amendment H-8294 to HF 2668
Relating to insurance coverage for biomarker testing
Never voted on
Filed April 9, 2024 in the House by
What it changes
- Page 1, by striking lines 14 through 17 and inserting: “c. “Clinical utility” means sufficient medical and scientific evidence indicating that the use of a biomarker test will provide meaningful information that affects treatment decisions and guides improvement of net health outcomes, including an improved quality of life or longer survival.” -1- HF 2668.4128.S (1) 90 mb 1/ 1